Figure 2.
Clinical symptoms of COVID-19 in β-Thalassemia heterozygotes patients and control: distribution of clinical symptoms of SARS-CoV-2-infected β-Thalassemia trait carriers (red box) and non-carriers (blue box).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.